Advertisement: TTP Killer 50
26 October, 2016 - 14:17 By News Desk

Storm Therapeutics

storm therapeutics, cancer, cambridge

Cambridge University spin-out Storm Therapeutics raised £12 million to develop novel cancer therapeutics. 

The cash is being used to identify small molecules that target RNA-modifying enzymes as the basis for the development of new cancer therapies. 

Storm Therapeutics is a spin-out from the Gurdon Institute and was created to commercialise the groundbreaking work of its founders, Professor Tony Kouzarides and Professor Eric Miska, in the field of RNA epigenetics.

stormtherapeutics.com

 

Newsletter Subscription

Stay informed of the latest news and features